{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-001033","form_type":"8-K","ticker":"PMDI","cik":"0000806517","company_name":"PSYCHEMEDICS CORP","filed_at":"2023-02-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.135024+00:00","generated_at":"2026-06-19T09:57:08.817058+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Psychemedics approves 2023 cash bonus plans for executives","bullets":["Compensation committee approved 2023 cash bonus arrangements for CEO, EVP, VP Lab Ops, and Controller.","Participants (excluding EVP) can earn up to 25% of base salary based on revenue, earnings, and individual goals.","EVP target is 20% base salary on revenue goal and 5% on earnings goal.","Committee retains right to withdraw, amend, or terminate bonus arrangements at any time.","Post-year-end CEO review will assess individual goal achievement for other participants."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-001033","json":"https://secwatch.observer/filing/0001171843-23-001033.json","markdown":"https://secwatch.observer/filing/0001171843-23-001033.md","text":"https://secwatch.observer/filing/0001171843-23-001033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/806517/000117184323001033/0001171843-23-001033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/806517/000117184323001033/f8k_021623.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T09:57:08.817058+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}